Fildena 50, like other medications containing sildenafil citrate, is classified as a phosphodiesterase type 5 (PDE5) inhibitor. This classification refers to its mechanism of action in the body.
Phosphodiesterase type 5 is an enzyme found primarily in the smooth muscle cells of the penis, lungs, and other areas of the body. In the context of erectile dysfunction, PDE5 plays a role in regulating blood flow by breaking down cyclic guanosine monophosphate (cGMP), a molecule that relaxes smooth muscle cells and dilates blood vessels.
By inhibiting the action of PDE5, medications like <b> Fildena 50 </b> prevent the breakdown of cGMP, leading to increased levels of cGMP in the smooth muscle cells of the penis. This results in relaxation of the smooth muscle and dilation of blood vessels, allowing for increased blood flow into the penis during sexual stimulation, which is necessary for achieving and maintaining an erection.
Therefore, Fildena 50 and other PDE5 inhibitors are used to treat erectile dysfunction by enhancing the body’s natural response to sexual stimulation, promoting the ability to achieve and sustain an erection.
Call: 876-927-9941–3 .
